Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Prioritisation routing

Prioritisation routing

Decision

Decision

Showing 1 to 50 of 373

TitlePrioritisation routingDecisionDecision date
Gilteritinib + daunorubicin + cytarabine for Acute myeloid leukaemia (AML) [TSID12331]None selectedAwaiting decision
Epcoritamab + R-CHOP for Diffuse large B-cell lymphoma (DLBCL) [TSID12334]None selectedAwaiting decision
Donanemab for reducing the risk of mild cognitive impairment in preclinical Alzheimer's disease [ID6675]None selectedAwaiting decision
Pozelimab with cemdisiran for treating symptomatic generalised myasthenia gravis [TSID12287]None selectedAwaiting decision
Lanadelumab for preventing recurrent attacks of hereditary angioedema in people 2 years and over [TSID12298]None selectedNot selected
Thermal Probe Ablation for abdominal wall endometriosisNone selectedAwaiting decision
Vacuum Assisted Excision for the removal of breast lesions of uncertain malignant potentialNone selectedNot selected
Sentinel Node Biopsy approved for pathological staging of clinically T1-T2 N0 oral cancerNone selectedNot selected
Mercaptamine hydrochloride for treating corneal cystine crystal deposits in people 6 months to under 2 years with cystinosis [TSID12261]None selectedNot selected
Digital flexor tenotomy for diabetic footNone selectedAwaiting decision
ID6611 Obesity, overweight - semaglutide (including review of TA875)None selectedAwaiting decision
Omental lymph node transfer for lymphoedema of the limbsNone selectedAwaiting decision
Modified release hydrocortisone capsules for treating adrenal insufficiency in people 12 years and over [TSID12254]None selectedNot selected
Dasiglucagon for treating severe hypoglycaemia caused by type 1 diabetes in people under 6 years [TSID12255]None selectedNot selected
Semaglutide for treating type 2 diabetes in people 10 to 17 years [TSID12249]None selectedNot selected
Male sling for stress urinary incontinenceNone selectedNot selected
Technologies to improve the detection of endometrial cancerNone selectedAwaiting decision
Dermal allograft augmentation in proximal humerus fracture fixationNone selectedAwaiting decision
Bioprosthetic or native Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA)None selectedAwaiting decision
Hip resurfacing for hip arthritisNone selectedAwaiting decision
Cryoablation for Desmoid-type FibromatosisNone selectedAwaiting decision
Transarterial radio embolisation for osteosarcoma liver metastasesNone selectedAwaiting decision
Ferric citrate for managing iron and serum phosphorus levels in anaemia associated with chronic kidney disease [TSID12221]None selectedNot selected
Cardiac ablation with percutaneous left atrial appendage occlusion (LAAO) for atrial fibrillationNone selectedAwaiting decision
Intradiscal Platelet Rich Plasma (PRP) Injections for Back Pain with Modic Type 1 ChangesNone selectedAwaiting decision
Robotic surgery for paediatric populationNone selectedNot selected
Orbital atherectomy for calcified coronary artery diseaseNone selectedNot selected
NeuroSAFE for Intra-operative frozen section evaluation of neurovascular bundle adjacent prostate capsule during radical prostatectomyNone selectedAwaiting decision
Bioinductive collagen scaffold (Regeneten) for rotator cuf repairNone selectedNot selected
Risankizumab for treating moderate to severe plaque psoriasis in people 6 to 17 years [TSID12204]None selectedNot selected
Rezafungin for preventing invasive fungal infections after an allogeneic blood and marrow transplant [TSID12165]None selectedNot selected
Leniolisib for untreated activated phosphoinositide 3-kinase delta syndrome in children 4 to 11 years [TSID12190]None selectedNot selected
Zanubrutinib for Chronic lymphocytic leukaemia (CLL) or Follicular lymphoma or Marginal zone lymphoma (MZL) or Waldenstrom's macroglobulinaemia [ID12199]None selectedNot selected
Subcutaneous pembrolizumab with platinum-based chemotherapy for untreated metastatic non-small-cell lung cancer [TSID12213]None selectedNot selected
Oral cabotegravir with rilpivirine for treating HIV-1 in people 12 to 17 years [TSID12214]None selectedNot selected
Long-acting injections of cabotegravir with rilpivirine for treating HIV-1 in people 12 to 17 years [TSID12219]None selectedNot selected
Lutetium (177Lu) oxodotreotide for treating SSTR-positive advanced or inoperable gastroenteropancreatic neuroendocrine tumours in people 12 to 17 years [TSID12154]None selectedNot selected
Epicranial focal cortex stimulation for drug-resistant focal epilepsyNone selectedNot selected
Excimer Laser Trabeculotomy (ELT) for glaucomaNone selectedAwaiting decision
Percutaneous nephrolithotomy for kidney stones greater than 1.5cmNone selectedNot selected
Diltiazem (Anatop, SLV-324, VEN 307) for Anal fissure [TSID 12100]None selectedNot selected
Mosunetuzumab for treating relapsed or refractory follicular lymphoma [TSID 12081]None selectedNot selected
Nifedipine - Lidocaine for Chronic Anal Fissure [TSID 12093]None selectedNot selected
Subcutaneous nivolumab–relatlimab for untreated unresectable or metastatic melanoma in people 12 years and over [TSID 12178]None selectedNot selected
Tolebrutinib for treating primary progressive multiple sclerosis [TSID12166]None selectedAwaiting decision
Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency (MA review of TA779) [ID6326]None selectedAwaiting decision
Sulthiame for treating self-limiting epilepsy with centrotemporal spikes in children TSID 12106None selectedNot selected
Apremilast for treating juvenile psoriatic arthritis in people 5 to 17 years [TSID12089]None selectedNot selected
Botulinum neurotoxin type E for treating moderate to severe glabellar lines [TSID12155]None selectedNot selected
Ocrelizumab for treating relapsing–remitting multiple sclerosis in people 10 to 17 years [TSID12164]None selectedNot selected

Results per page

  1. 10
  2. 25
  3. 50
  4. All